🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

HF vs NIV in Acute Cardiogenic Pulmonary Edema

RecruitingNAAges 18 Years - anyAllFondazione Policlinico Universitario Agostino Gem…
NCT05989139 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study's primary aim is * to compare the effects of two different ventilation modalities, non-invasive positive-pressure ventilation (NPPV) and high-flow nasal cannulae (HFNC), in the acute cardiogenic pulmonary edema (ACPE) setting, in terms of echocardiographic parameters of RV systolic and RV strain. * to determine the differences of the two interventions on other hemodynamic parameters echocardiographically assessed. * to assess the differences between the two interventions on physiological parameters, i.e., mean arterial pressure (MAP), heart rate (HR), respiratory rate (RR), oxygen saturation (SpO2), and on arterial blood gases (ABG) analysis parameters (i.e. relief of dyspnea and respiratory distress, patient comfort). Enrolled patients will receive NPPV and HFNC oxygen therapy in a randomized, cross-over fashion, for 40 minutes each (time 0, T0 and time 1, T1), followed by c

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 y.o.; * Clinical diagnosis of ACPE in the setting of either AMI, acute myocarditis, acute/chronic severe mitral/aortic valve regurgitation, severe mitral/aortic stenosis, acute/chronic HF with rLVEF diagnosed according to European Society of Cardiology (ESC) guidelines \[4\]; * Hypertensive crisis with systolic blood pressure \>200 mmHg; * Other congenital or acquired structural heart disease causing post capillary pulmonary hypertension or combination of the previous. * Written informed consent. Exclusion Criteria: * Age \<18 y.o.; * Hypercapnia with respiratory acidosis (PaCO2 \> 45 mmHg with pH \< 7.35); * History of fever in the previous 4 days; * White blood cell count \> 12.000; * Increased procalcitonin serum levels; * Consolidative areas at chest radiograph; * Hypotension (systolic blood pressure \< 85 mmHg); * Cardiogenic shock; * Right ventricular (RV) dysfunction; * Previous cardiac surgery, * Glasgow Coma Scale score ≤ 8 points; * Impaired ability to protect the airway from aspiration; * Orotracheal intubation needed due to cardiopulmonary resuscitation maneuvers; * Respiratory arrest; * Severe hemodynamic instability; * Facial trauma, burns, recent facial surgery or facial anatomy which prevents from the application of the NPPV interface to patient's face.
💊

What it tests

  • NPPV/HFNC
  • HFNC/NPPV
📍

Where

1 site
Fondazione IRCCS Policlinico Agostino Gemelli Roma
Roma, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy